Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • qiuyuxinhan
    Junior Member
    • Apr 2014
    • 8

    #1

    Which strategy or strategies should I use?

    I am a newer for NGS. Recently I got 8 samples of NGS data from the Solid 5500xl. The average depth is about 10x, some maybe deeper. All of the samples are sporadic. People who has this kind of disease will die before they grow up. So lots of evidences make us believe that this kind of disease should be a de novo mutation. Which strategy or strategies should I use that could help me find the right gene? Thank you very much!
  • dpryan
    Devon Ryan
    • Jul 2011
    • 3478

    #2
    Are the samples from related individuals?

    Comment

    • Zaag
      Senior Member
      • Nov 2009
      • 112

      #3
      Is it whole genome, exome, panels? Do you have reads or alignments or variants?

      Comment

      • qiuyuxinhan
        Junior Member
        • Apr 2014
        • 8

        #4
        They don't have any relationship with each other.

        Comment

        • qiuyuxinhan
          Junior Member
          • Apr 2014
          • 8

          #5
          We did the whole exon sequence by the solid 5500xl.

          Comment

          • swbarnes2
            Senior Member
            • May 2008
            • 910

            #6
            In brief, align to reference genomes, human, I guess, then call SNPs. Best case, you are looking for a gene where all your samples have SNPs which cause highly deleterious changes to the protein. If your samples are not related, they probably won't all share the exact same mutation.

            If you don't have that, you'll have to think a little harder. Maybe there are a few genes mutated in the same pathway? Maybe you have a CNV? It's always possible that your mutation is not even in the exome, in which case, your data won't show it.

            Comment

            • qiuyuxinhan
              Junior Member
              • Apr 2014
              • 8

              #7
              First of all, thank you very much for your guidance! We have checked the mutations which all 8 samples shared. But we didn't find any reasonable gene for our case. We also checked the CNV before we did the NGS. As you said, maybe there are a few genes mutated in the same pathway, but how could we annotate this? Which software could we use to analysis this ? Thank you again!

              Comment

              • Brian Bushnell
                Super Moderator
                • Jan 2014
                • 2709

                #8
                Let's assume this is a one-or-two-gene disorder, since otherwise, most methodologies just won't work.

                It's unreasonable to expect unrelated people to share a mutation. More likely, the related affecteds have a homozygous mutation in the same genes(s), due to inbreeding, which is highly probable for fatal genetic conditions. In this case it is best to sequence related individuals and find genes in which the unaffecteds have heterozygous mutations, but the affecteds have homozygous mutations.

                One way to isolate responsible genes is to sequence multiple generations of related individuals (like great-grandparents, grandparent, parents/aunts/uncles, siblings/cousins, etc), and use software to determine inheritance. You don't even need sequencing for most of them; a cheaper SNP array is fine. This will allow you to isolate the genes (or areas) that are unique from the rest of the family (due to crossover events) and thus may be causing problems. Then, armed with the most probable locations, you can examine the affecteds' sequences in detail to determine the problem.

                Comment

                Latest Articles

                Collapse

                • SEQadmin2
                  Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
                  by SEQadmin2



                  Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

                  Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
                  ...
                  10-14-2026, 09:55 AM
                • SEQadmin2
                  New Genomics Technologies Take Aim at Long-Standing Limits
                  by SEQadmin2


                  Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

                  We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
                  ...
                  09-28-2026, 10:25 AM

                ad_right_rmr

                Collapse

                News

                Collapse

                Topics Statistics Last Post
                Started by SEQadmin2, 10-22-2026, 11:13 AM
                0 responses
                55 views
                0 reactions
                Last Post SEQadmin2  
                Started by SEQadmin2, 10-22-2026, 10:48 AM
                0 responses
                40 views
                0 reactions
                Last Post SEQadmin2  
                Started by SEQadmin2, 10-15-2026, 10:52 AM
                0 responses
                46 views
                0 reactions
                Last Post SEQadmin2  
                Started by SEQadmin2, 10-14-2026, 05:39 AM
                0 responses
                46 views
                0 reactions
                Last Post SEQadmin2  
                Working...